BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28779950)

  • 21. Hepatocellular carcinoma response to transcatheter arterial chemoembolisation using automatically generated pre-therapeutic tumour volumes by a random forest-based segmentation protocol.
    Khalaf AM; Fuentes D; Morshid A; Kaseb AO; Hassan M; Hazle JD; Elsayes KM
    Clin Radiol; 2019 Dec; 74(12):974.e13-974.e20. PubMed ID: 31521326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CT findings of completely regressed hepatocellular carcinoma with main portal vein tumor thrombosis after transcatheter arterial chemoembolization.
    Yoon JH; Kim HC; Chung JW; Yoon JH; Jae HJ; Park JH
    Korean J Radiol; 2010; 11(1):69-74. PubMed ID: 20046497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Multiple-phase spiral computerized tomography of small hepatocellular carcinoma: technique optimization and diagnostic yield].
    Catalano O; Cusati B; Sandomenico F; Nunziata A; Lobianco R; Siani A
    Radiol Med; 1999; 98(1-2):53-64. PubMed ID: 10566297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Transarterial chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis--experiences].
    Herber S; Pitton M; Mönch C; Schneider J; Manzl N; Kummer I; Kanzler S; Schuchmann M; Junginger T; Düber C; Otto G
    Zentralbl Chir; 2007 Aug; 132(4):306-15. PubMed ID: 17724633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidetector CT of the liver and hepatic neoplasms: effect of multiphasic imaging on tumor conspicuity and vascular enhancement.
    Francis IR; Cohan RH; McNulty NJ; Platt JF; Korobkin M; Gebremariam A; Ragupathi KI
    AJR Am J Roentgenol; 2003 May; 180(5):1217-24. PubMed ID: 12704026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
    Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
    Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iodized oil accumulation in hypervascular hepatocellular carcinoma after transcatheter arterial chemoembolization: comparison of imaging findings with CT during hepatic arteriography.
    Fujita T; Ito K; Tanabe M; Yamatogi S; Sasai H; Matsunaga N
    J Vasc Interv Radiol; 2008 Mar; 19(3):333-41. PubMed ID: 18295691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computed tomography predictors of hepatocellular carcinoma tumour necrosis after chemoembolization.
    Bryant MK; Dorn DP; Zarzour J; Smith JK; Redden DT; Saddekni S; Abdel Aal AK; Gray SH; Eckhoff DE; Dubay DA
    HPB (Oxford); 2014 Apr; 16(4):327-35. PubMed ID: 23980917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arterial portography during transarterial chemoembolization: still a necessity in the age of contrast-enhanced cross-sectional imaging?
    Hui TC; Pua U
    J Vasc Interv Radiol; 2014 Jan; 25(1):41-6. PubMed ID: 24290098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spectral CT in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma: A retrospective study.
    Wang J; Shen JL
    Medicine (Baltimore); 2017 Dec; 96(52):e9236. PubMed ID: 29384909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging.
    Oliver JH; Baron RL; Federle MP; Rockette HE
    AJR Am J Roentgenol; 1996 Jul; 167(1):71-7. PubMed ID: 8659425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization.
    Kim JH; Yoon HK; Ko GY; Gwon DI; Jang CS; Song HY; Shin JH; Sung KB
    Radiology; 2010 Apr; 255(1):270-7. PubMed ID: 20308463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel treatment strategy for advanced hepatocellular carcinoma: combination of conventional transcatheter arterial chemoembolization and modified method with portal vein occlusion for cases with arterioportal shunt: a preliminary study.
    Yasui D; Murata S; Ueda T; Sugihara F; Onozawa S; Kawamoto C; Kumita S
    Acta Radiol; 2018 Mar; 59(3):266-274. PubMed ID: 28651444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study of the liver and the portal venous system with digital rotational angiography].
    Gattoni F; Dova S; Tonolini M; Uslenghi CM
    Radiol Med; 2001 Mar; 101(3):118-24. PubMed ID: 11402948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Multiphasic spiral computed tomography in hepatocarcinoma. An evaluation following different percutaneous ablative procedures].
    Catalano O; Esposito M; Lobianco R; Cusati B; Altei F; Siani A
    Radiol Med; 1999 Dec; 98(6):500-8. PubMed ID: 10755012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcatheter arterial chemoembolization combined with radiofrequency ablation can improve survival of patients with hepatocellular carcinoma with portal vein tumour thrombosis: extending the indication for ablation?
    Zheng JS; Long J; Sun B; Lu NN; Fang D; Zhao LY; Du N
    Clin Radiol; 2014 Jun; 69(6):e253-63. PubMed ID: 24581962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multidetector CT in evaluating blood supply of hepatocellular carcinoma after transcatheter arterial chemoembolization.
    Guan YS; Zheng XH; Zhou XP; Huang J; Sun L; Chen X; Li X; He Q
    World J Gastroenterol; 2004 Jul; 10(14):2127-9. PubMed ID: 15237450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parametric response mapping of contrast-enhanced biphasic CT for evaluating tumour viability of hepatocellular carcinoma after TACE.
    Hinrichs JB; Shin HO; Kaercher D; Hasdemir D; Murray T; Kaireit T; Lutat C; Vogel A; Meyer BC; Wacker FK; Rodt T
    Eur Radiol; 2016 Oct; 26(10):3447-55. PubMed ID: 26769666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the relationship between hepatocellular carcinoma location and transarterial chemoembolization efficacy.
    Miki I; Murata S; Uchiyama F; Yasui D; Ueda T; Sugihara F; Saito H; Yamaguchi H; Murakami R; Kawamoto C; Uchida E; Kumita SI
    World J Gastroenterol; 2017 Sep; 23(35):6437-6447. PubMed ID: 29085193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis.
    Kim JH; Yoon HK; Kim SY; Kim KM; Ko GY; Gwon DI; Sung KB
    Aliment Pharmacol Ther; 2009 Jun; 29(12):1291-8. PubMed ID: 19392861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.